Opus Genetics, Inc. Stock Split Ratio
Opus Genetics, Inc. (IRD) reported Stock Split Ratio of 105.65% for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-24.
Discontinued › Notes › Stockholders' Equity Note
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2022-03-24
- Opus Genetics, Inc. stockholders' equity note, stock split, conversion ratio for the quarter ending 2021-03-31 was 105.65%.
- Opus Genetics, Inc. stockholders' equity note, stock split, conversion ratio for fiscal 2021 was 105.65%, a 0.00% change from fiscal 2020.
- Opus Genetics, Inc. stockholders' equity note, stock split, conversion ratio for fiscal 2020 was 105.65%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio | Stockholders' Equity Note, Stock Split, Conversion Ratio 3 month | Stockholders' Equity Note, Stock Split, Conversion Ratio 6 month | Stockholders' Equity Note, Stock Split, Conversion Ratio 9 month | Stockholders' Equity Note, Stock Split, Conversion Ratio 12 month |
|---|---|---|---|---|---|
| 2021-12-31 | 105.65% 10-K · filed 2022-03-24 | ||||
| 2021-09-30 | 105.65% 10-Q · filed 2021-11-12 | ||||
| 2021-06-30 | 105.65% 10-Q · filed 2021-08-12 | ||||
| 2021-03-31 | 105.65% 10-Q · filed 2021-05-07 | ||||
| 2020-12-31 | 105.65% 10-K · filed 2021-03-11 | ||||
| 2020-11-05 | 105.65% 10-K · filed 2022-03-24 | ||||
| 2019-04-12 | 8.30% 10-K · filed 2020-02-21 | ||||
| 2017-05-05 | 10.00% 10-K · filed 2019-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |